DBV Technologies (DBVT) Assets Average (2016 - 2026)
DBV Technologies (DBVT) reported Assets Average of $250.0 million for Q1 2026, up 330.3% year-over-year from $58.1 million in Q1 2025, and up 45.3% quarter-over-quarter from $172.1 million in Q4 2025.
DBV Technologies (DBVT) Assets Average (2016 - 2026) Analysis & Trends
DBV Technologies (DBVT) has 10 years of Assets Average data on file, last reported at $250.0 million in Q1 2026.
- Assets Average for Q1 2026 came in at $250.0 million, up 330.3% year-over-year; the trailing twelve-month figure through Mar 2026 was $250.0 million (up 330.3% YoY), and the FY2025 annual result was $149.7 million, up 20.4% from the prior year.
- Assets Average advanced to $250.0 million in Q1 2026 per DBVT's latest filing, from $172.1 million in the prior quarter.
- Over five years, Assets Average peaked at $266.5 million in Q3 2022 and troughed at $58.1 million in Q1 2025.
- A 5-year average of $169.6 million and a median of $172.1 million in 2025 frame the typical range for Assets Average.
- The sharpest annual moves came in 2025 and 2026: Assets Average slumped 64.66% in 2025, then jumped 330.3% in 2026.
- A 5-year view of Assets Average shows it stood at $247.3 million in 2022, then decreased by 24.64% to $186.4 million in 2023, then tumbled by 57.42% to $79.4 million in 2024, then jumped by 116.87% to $172.1 million in 2025, then jumped by 45.3% to $250.0 million in 2026.
- Business Quant data shows DBVT's Assets Average at $250.0 million in Q1 2026, $172.1 million in Q4 2025, and $127.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 26.03 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 40.89 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 660.38 Mn |
| 10 | DBV Technologies | 6.63 Bn | 6.41 Bn | -3.90 Mn | 250.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 250.05 Mn |
| Dec 31, 2025 | 172.10 Mn |
| Sep 30, 2025 | 126.96 Mn |
| Jun 30, 2025 | 97.00 Mn |
| Mar 31, 2025 | 58.11 Mn |
| Dec 31, 2024 | 79.36 Mn |
| Sep 30, 2024 | 103.62 Mn |
| Jun 30, 2024 | 130.04 Mn |
| Mar 31, 2024 | 164.44 Mn |
| Dec 31, 2023 | 186.38 Mn |
| Sep 30, 2023 | 203.65 Mn |
| Jun 30, 2023 | 225.22 Mn |
| Mar 31, 2023 | 239.72 Mn |
| Dec 31, 2022 | 247.32 Mn |
| Sep 30, 2022 | 266.55 Mn |
| Jun 30, 2022 | 201.28 Mn |
| Mar 31, 2022 | 132.15 Mn |
| Dec 31, 2021 | 158.82 Mn |
| Sep 30, 2021 | 185.75 Mn |
| Jun 30, 2021 | 210.99 Mn |